Cover Image
市場調查報告書

Paroxetine的中國市場分析

Investigation Report on China Paroxetine Market, 2010-2019

出版商 China Research and Intelligence 商品編碼 334090
出版日期 內容資訊 英文 35 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
Paroxetine的中國市場分析 Investigation Report on China Paroxetine Market, 2010-2019
出版日期: 2015年07月02日 內容資訊: 英文 35 Pages
簡介

根據世界衛生組織(WHO)指出,憂鬱症是發病率.∼5%的常見疾病(情緒障礙)。中國憂鬱症患者已達9000萬人以上,今後也在經濟發展、生活習慣變化伴隨的精神壓力增大下,預測病患會更進一步地增加。Paroxetine是選擇性性血清再吸收抑制劑 (SSRI) 的代表性產品,主要用於憂鬱症、強迫性精神官能症,社會不安的治療上。Paroxetine在中國國內上市以來其銷售額幾乎是持續擴大,2005年不到6000萬人民幣,但到2013年一路以17.3%的年平均成長率(CAGR)擴大,到2013年已達到2億400萬人民幣的規模。

本報告提供中國的Paroxetine的市場相關分析,提供您整體市場規模趨勢(過去5年份)和國內價格趨勢,各企業·給藥型態別的市場佔有率,主要製造商簡介,未來性的市場趨勢預測(今後5年份)等調查評估。

第1章 Paroxetine的相關概念

  • 症狀
  • 全球市場的銷售情形

第2章 中國的Paroxetine市場概況

  • 中國國內的Paroxetine的專利申請·認證情形
  • 主要製造商
  • 市場規模

第3章 Paroxetine銷售情形分析 (過去5年份)

  • 銷售額
    • 整體銷售額
    • 各地區的銷售額
  • 銷售量
    • 整體銷售量
    • 各地區的銷售量

第4章 中國的Paroxetine市場:主要廠商的市場佔有率分析 (過去5年份)

  • 市場佔有率 (以銷售額為準)
  • 市場佔有率 (以銷售量為準)

第5章 中國的Paroxetine市場:各劑型分析 (過去5年份)

  • 各劑型的市場佔有率 (以銷售額為準)
  • 各劑型的市場佔有率 (以銷售量為準)

第6章 Paroxetine的醫院用標準價格

  • Sino-American Tianjin Smith Kline & French Laboratories Ltd (商標名:Seroxat)
  • GlaxoSmithKline plc (加拿大) (商標名:Seroxat)
  • Beijing Wansheng Pharmaceutical Co., Ltd
  • Zhejiang Huahai Pharmaceutical Co., Ltd (商標名:LEYOU)
  • Zhejiang Jianfeng Pharmaceutical Holdings (商標名:Shutanluo)

第7章 中國國內的Paroxetine的主要製造商 (過去5年份)

  • Sino-American Tianjin Smith Kline & French Laboratories Ltd
  • Beijing Wansheng Pharmaceutical Co., Ltd
  • Zhejiang Huahai Pharmaceutical Co., Ltd
  • Zhejiang Jianfeng Pharmaceutical Holdings
  • GlaxoSmithKline plc (CA)

第8章 中國的Paroxetine市場未來展望 (今後5年份)

  • 市場規模的預測
  • 競爭環境預測

圖表一覽

目錄
Product Code: 1507251

According to WHO, depression, an affective mental disorder, is quite common with an incidence of 3-5%. Currently, the number of depression patients has exceeded 90 million in China and still keeps increasing. It is expected that by 2020, depression will become the second biggest threat to human health.

As a drug of the selective serotonin reuptake inhibitor (SSRI) type, paroxetine is mainly used for the treatment of depression, obsessive-compulsive disorder and social anxiety and is among one of the three SSRI drugs with certain efficacy (the other two being fluoxetine and paroxetine).

Paroxetine develops fast after entering China despite a slight decline in 2014, annual sales value rising from less than CNY 60 million in 2005 to CNY 204 million in 2013 and CAGR during this period reaching up to 17.3%. Sino-American Tianjin Smith Kline & French Laboratories Ltd, GlaxoSmithKline plc (CA), Beijing Wansheng Pharmaceutical Co., Ltd, Zhejiang Huahai Pharmaceutical Co., Ltd and Zhejiang Jianfeng Pharmaceutical Holdings occupy the majority of the Chinese market, among which Sino-American Tianjin Smith Kline & French Laboratories Ltd had the largest market share of about 69% for sales value in 2014.

With the increased mental pressure brought about by economic development and lifestyle change, the number of depression patients keeps growing too. Therefore, the market size of paroxetine is expected to expand in the next few years in China.

Readers can get at least the following information from this report:

  • market size of paroxetine in China
  • competitive landscape of paroxetine in Chinese market
  • price of paroxetine made by different enterprises in China
  • market outlook of paroxetine in China

The author suggests the following groups of people purchase this report:

  • manufacturers of antidepressant
  • investors/ research institutions interested in Chinese medicine market
  • any interest in the Chinese medicine market, please contact CRI for customized survey service

Table of Contents

1. Related Concepts of Paroxetine

  • 1.1. Indication
  • 1.2. Sales Status in Global Market

2. Market Profile of Paroxetine in China

  • 2.1. Patent and Approval Status of Paroxetine in China
  • 2.2. Major Manufacturers
  • 2.3. Market Size

3. Survey on Sales Status of Paroxetine in China, 2010-2014

  • 3.1. Sales Value
    • 3.1.1. Overall Sales Value
    • 3.1.2. Sales Value by Regions
  • 3.2. Sales Volume
    • 3.2.1. Overall Sales Volume
    • 3.2.2. Sales Volume by Regions

4. Survey o Market Share of Major Manufacturers of Paroxetine in China, 2010-2014

  • 4.1. Market Share by Sales Value
  • 4.2. Market Share by Sales Volume

5. Survey on Dosage Forms of Paroxetine in China, 2010-2014

  • 5.1. Share of Different Dosage Forms by Sales Value
  • 5.2. Share of Different Dosage Forms by Sales Volume

6. Reference Price of Paroxetine in Chinese Hospitals in 2014

  • 6.1. Sino-American Tianjin Smith Kline & French Laboratories Ltd (Trade Name: Seroxat)
  • 6.2. GlaxoSmithKline plc (Canada) (Trade Name: Seroxat)
  • 6.3. Beijing Wansheng Pharmaceutical Co., Ltd
  • 6.4. Zhejiang Huahai Pharmaceutical Co., Ltd (Trade Name: LEYOU)
  • 6.5. Zhejiang Jianfeng Pharmaceutical Holdings (Trade Name: Shutanluo)

7. Major Manufacturers of Paroxetine in Chinese Market, 2010-2014

  • 7.1. Sino-American Tianjin Smith Kline & French Laboratories Ltd
  • 7.2. Beijing Wansheng Pharmaceutical Co., Ltd
  • 7.3. Zhejiang Huahai Pharmaceutical Co., Ltd
  • 7.4. Zhejiang Jianfeng Pharmaceutical Holdings
  • 7.5. GlaxoSmithKline plc (CA)

8. Market Outlook of Paroxetine in China, 2015-2019

  • 8.1. Forecast of Market Size
  • 8.2. Forecast of Competitive Landscape

Table of Selected Charts

  • Chart Patent Status of Paroxetine in China
  • Chart Approval Information of Paroxetine in China
  • Chart Sales Status of Paroxetine in China
  • Chart Sales Value of Paroxetine in China, 2010-2014
  • Chart Sales Value of Paroxetine in Some Regions in China, 2010-2014
  • Chart Sales Volume of Paroxetine in China, 2010-2014
  • Chart Market Share of TOP3 Manufacturers of Paroxetine for Sales Value in China, 2010-2014
  • Chart Sales Value and Market Share of Paroxetine Made by Tianjin SK & F in China, 2010-2014
  • Chart Sales Value and Market Share of Paroxetine Made by Zhejiang Huahai in China, 2010-2014
  • Chart Sales Value and Market Share of Paroxetine Made by Zhejiang Jianfeng in China, 2010-2014
  • Chart Sales Value and Market Share of Paroxetine Made by Other Enterprises in China, 2010-2014
  • Chart Price of Paroxetine Made by Sino-American Tianjin Smith Kline & French Laboratories Ltd in Some Chinese Cities in 2014
  • Chart Price of Paroxetine Made by GlaxoSmithKline plc (CA) in Some Chinese Cities in 2014
  • Chart Price of Paroxetine Made by Beijing Wansheng Pharmaceutical Co., Ltd in Some Chinese Cities in 2014
  • Chart Price of Paroxetine Made by Zhejiang Huahai Pharmaceutical Co., Ltd in Some Chinese Cities in 2014
  • Chart Price of Paroxetine Made by Zhejiang Jianfeng Pharmaceutical Holdings in Some Chinese Cities in 2014
Back to Top